-
Company Insights
Innovation and Patenting activity of u-blox Holding AG Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of u-blox Holding AG Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – U-87 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - U-87 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.U-87 in Pancreatic Cancer Drug Details:U-87 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – U-01 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - U-01 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.U-01 in Relapsed Acute Myeloid Leukemia Drug Details:U-01 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drug Details:Gene therapy is under development for the...
-
Product Insights
Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – U-01 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - U-01 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.U-01 in B-Cell Acute Lymphocytic Leukemia (B-Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Endometrial Cancer Drug Details: Palbociclib (Ibrance, Agatha) is a...
-
Sector Analysis
South Korea Telecom Operators Country Intelligence Report
South Korea Telecom Operators Country Intelligence Overview The total telecom and pay-TV service revenue in South Korea was estimated at $31.9 billion in 2023 and will grow at a CAGR of more than 10% during 2023-2028, mainly driven by revenue contribution from the mobile data segment. This increase will be driven by operators’ focus on 5G network expansion and K-Network 2030 strategy, which aims to develop public-private partnerships to develop 6G technologies and bolster the network supply chain. The South...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...